QuickShot Testosterone is a drug-device combination that delivers testosterone enanthate via a subcutaneous (SC) auto-injector. This route of administration removes the risk of transference that is ...
Xyosted carries a Boxed Warning regarding blood pressure increases that may potentially increase the risk for major adverse cardiovascular events. The Food and Drug Administration (FDA) has approved ...
EWING, N.J., May 16, 2017 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) announced that data from its Phase 3 study of the pharmacokinetics and safety of subcutaneous testosterone enanthate ...
* Antares Pharma Inc - submitted a new drug application (nda) to U.S. Food And Drug Administration (FDA) for quickshot testosterone * Antares Pharma Inc - quickshot testosterone auto injector has not ...
Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has received the Food and Drug Administration’s permission for Testosterone Cypionate Injection 1,000 mg/10 ml (100 mg/ml) and 2,000 mg/10 ml ...
The US Food and Drug Administration (FDA) has declined to approve a new drug application (NDA) for testosterone enanthate (Xyosted, Antares Pharma) in a proprietary autoinjector and has raised two ...
Boys conceived using intra-cytoplasmic sperm injection (ICSI) have lower serum testosterone levels than their naturally conceived counterparts, according to a recent study from Denmark where 1.5% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback